Localization of transforming growth factor-β1 precursor and latent TGF-β1 binding protein in colorectal adenomas

Digestive Diseases and Sciences

Volumn 41, Issue 9, 1996, Pages 1741-1748

  Van Laethem, Jean Luc ^a   Resibois, Anne ^b   Adler, Michael ^b   Peny, Marie Odile ^b   Ohtani, Haruo ^b   Robberecht, Patrick ^b  

^a ERASME HOSPITAL   (Belgium)

^b NONE

Author keywords

Colorectal adenoma; Colorectal tumorigenesis; Latent TGF 1 binding protein; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ADENOMA; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0029740344     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088739     Document Type: Article

References (32)

1. Muto T, Bussey HJR, Morson BC: The evolution of cancer of the colon and rectum. Cancer 36:2251-2270, 1975
2. Ferron ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990
3. Smith K, Johnson K, Bryan T, Hill D, Markowitz S, Willson J, Paraskeva C, Petersen G, Hamilton S, Vogelstein B, Kinzler K: The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 90:2846-2850, 1993
4. Coffey R, Goustin A, Mangelsdorf-Soderqvist A, Shipley G, Wolfshohl J, Carpenter G, Moses H: Transforming growth factor α and β expression in human colon cancer lines: Implications for an autocrine model. Cancer Res 47:4590-4594, 1987
5. Lahm H, Odartchenko N: Role of transforming growth factor β in colorectal cancer. Growth Factors 9:1-9, 1993
6. 1 binding protein in human gastrointestinal carcinomas: Qualitative difference between cancer cells and stromal cells. Cancer Res 53:183-190, 1993
7. Barnard J, Beauchamps R, Coffey R, Moses H: Regulation of intestinal cell growth by transforming growth factor β. Proc Natl Acad Sci USA 86:1578-1582, 1989
8. Manning A, Williams A, Game S, Paraskeva C: Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β(TGF-β): Conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene 6:1471-1476, 1991
9. 1 on mitogenic response, transforming growth factor α, and c-myc in quiescent, well-differentiated colon carcinoma cells. Cancer Res 50:7581-7586, 1990
10. Hooscin N, Brattain D, McKnight M, Levine A, Brattain M: Characterization of, the inhibitory effects of transforming growth factor β on a human colon carcinoma cell line. Cancer Res 47:2950-2954, 1987
11. 1. Exp Cell Res 181:442-453, 1989
12. Barnard J, Warwick G, Gold L: Localization of transforming growth factor β isoforms in the normal murine small intestine and colon. Gastroenterology 105:67-73, 1993
13. Avery A, Paraskeva C, Hall P, Flanders KC, Sporn M, Moorghen M: TGF-β expression in the human colon: Differential immunostaining along crypt epithelium. Br J Cancer 68:137-139, 1993
14. Friess H, Yamanaka Y, Buchler M, Ebert M, Beger H, Gold L, Korc M: Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates well with decreased survival. Gastroenterology 105:1846-1856, 1993
15. McCune BK, Mullin B, Flanders K, Jaffurs W, Mullen LT, Sporn MB: Localization of transforming growth factor-β isotypes in lesions of the human breast. Hum Pathol 23:13-20, 1992
16. Derynck R, Jarrett J, Chen E, Eaton D, Bell J, Assoian R, Roberts A, Sporn M, Goeddel D: Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705, 1985
17. Gentry L, Webb N, Lin G, Brunner A, Ranchalis J, Twardzik D, Lioubin M, Marquardt H, Purchio A: Type I transforming growth factor β: Amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells. Mol Cell Biol 7:3418-3427, 1989
18. 1: Purification from human platelets and structural characterization. J Biol Chem 263:6407-6415, 1988
19. 1 with multiple repeat sequences. Cell 61:1051-1061, 1990
20. 1. EMBO J 10:1091-1101, 1991
21. Flaumenhaft R, Abe M, Sato Y, Miyazono K, Harpel J, Heldin C, Rifkin D: Role of latent TGF-β binding protein in the activation of latent TGF-β by cocultures of endothelial and smooth muscle cells. J Cell Biol 120:995-1002, 1993
22. Morson BC, Dawson IMP: Benign epithelial tumors and polyps. In Gastrointestinal Pathology, 3rd ed. London, Blackwell Scientific, 1990, pp 563-580
23. Hsu S, Raine L, Fanger H: Use of avidin-biotin-proxydose complex (ABC) in imrnunoperoxydase techniques. J Histochem Cytochem 29:577-580, 1981
24. 1. In Peptide Growth Factors and Their Receptors. M Sporn, A Roberts (eds). Berlin, Springer-Verlag, 1990, pp 419-472
25. Moses H, Yang E, Pietenpol J: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 63:245-247, 1990
26. 1: Histochemical localization with antibodies to different epitopes. J Cell Biol 108:653-660, 1989
27. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641, 1990
28. Sporn M, Roberts A: Transforming growth factor-β: Recent progress and new challenges. J Cell Biol 119:1017-1021, 1992
29. Roberts A, Sporn M, Assoian R, Smith J, Roche N: Transforming growth factor type-β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl cad Sci USA 83:4167-4171, 1986
30. 1 can play an important role in the development of tumourigenesis by its action for angiogenesis: Validity of neutralizing antibodies to block tumor growth. BBA 1137:189-196, 1992
31. 1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol 124:171-181, 1994
32. 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J Biol Chem 267:19482-19488, 1992